Clinical trials of:
• rotigotine dopamine agonist patch in Parkinson’s disease
(PD)
•
synthetic human growth hormone in multiple system atrophy (MSA)
•
riluzole in MSA and progressive supranuclear palsy (PSP).
•
National PD-SURG trials in PD
•
London/Lund/Marburg programme of fetal nigral mesencephalic grafting
in PD.
•
Development of MSA rating scale and therapeutic trial assessment protocols,
and of Quality of Life scales for MSA and PSP.
Clinical research projects on:
•
repetitive transcranial magnetic stimulation (rTMS) in movement disorders
•
the syndrome of fixed dystonia
•
DYT1 gene carriers with and without dystonia.
Group members
Prof. Niall Quinn MA, MD, FRCP n.quinn@ion.ucl.ac.uk
Prof. Kailash Bhatia MD, DM, FRCP k.bhatia@ion.ucl.ac.uk
Dr Caroline Selai MSc, PhD c.selai@ion.ucl.ac.uk
Collaborations:
1 Other research departments in the Institute of Neurology
2 MRC Cyclotron Unit (Prof D J Brooks), RPMS, Hammersmith Hospital
3 European MSA Study Group (www.EMSA-SG.org)
4 Wallenberg Neuroscience Centre, Lund University, Sweden
5 European Dystonia Epidemiology Group
|